PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Future Biologics, Lawrenceville, USA.\', \'BioIntegrate, Lawrenceville, USA.\', \'South Texas Orthopedic Research Institute (STORI Inc), Laredo, USA.\', \'Veterans in Pain, Los Angeles, USA.\', \'Department of Stem Cell & Regenerative Medicine, Centre for Interdisciplinary Research, D. Y. Patil Education Society (Institution Deemed to Be University), Kolhapur, India.\', \'Advancells Group, Noida, India.\', \'Future Physicians of South Texas, San Antonio, USA.\', \'School of Osteopathic Medicine, University of the Incarnate Word, San Antonio, USA.\', \'The Institute of Musculoskeletal Excellence (TIME Orthopaedics), Laredo, USA.\', \'El-Amin Orthopaedic & Sports Medicine Institute, Lawrenceville, USA.\', \'Department of Musculoskeletal Disorders, School of Medicine and Surgery, University of Salerno, Fisciano, Italy.\', \'San Giovanni Di Dio E Ruggi D\'Aragona Hospital \'Clinica Orthopedica\' Department, Hospital of Salerno, Salerno, Italy.\', \'Queen Mary University of London, Barts and the London School of Medicine and Dentistry, Centre for Sports and Exercise Medicine, London, England.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/14712598.2021.1921141
?:hasPublicationType
?:journal
  • Expert opinion on biological therapy
is ?:pmid of
?:pmid
?:pmid
  • 33886388
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.117
?:rankingScore_hIndex
  • 73
is ?:relation_isRelatedTo_publication of
?:title
  • Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all